Steven Ringold, DVM, DACVR, discusses his Fetch On-Demand lecture and what attendees can learn from it.

At Children’s Hospital of Philadelphia, an 11-year-old girl with severe beta thalassamia, became the first pediatric patient to receive Zyntelgo, the first FDA-approved gene therapy for ...

A new study has created the first normative charts of brain functional development from birth to six years old, highlighting ...

[7] Increased autoimmunity appears to be primarily the result of the combined effects of the reduction in naive T cells (produced by thymus involution) in concert with an activation of self ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Ablation of RIPK1 in αβT cells results in ...

The distinct pattern of expression in postembryonic tissues may be of importance for EPHA3 as a novel focus for targeted therapy, as with scant receptor expression in normal cells, a satisfactory ...